IRIS Accounts Production v25.4.0.155 06682721 Board of Directors 1.4.24 31.3.25 31.3.25 16.12.25 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066827212024-03-31066827212025-03-31066827212024-04-012025-03-31066827212023-03-31066827212023-04-012024-03-31066827212024-03-3106682721ns15:EnglandWales2024-04-012025-03-3106682721ns14:PoundSterling2024-04-012025-03-3106682721ns10:Director12024-04-012025-03-3106682721ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3106682721ns10:SmallEntities2024-04-012025-03-3106682721ns10:Audited2024-04-012025-03-3106682721ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3106682721ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3106682721ns10:FullAccounts2024-04-012025-03-3106682721ns10:Director22024-04-012025-03-3106682721ns10:Director32024-04-012025-03-3106682721ns10:CompanySecretary12024-04-012025-03-3106682721ns10:RegisteredOffice2024-04-012025-03-3106682721ns5:CurrentFinancialInstruments2025-03-3106682721ns5:CurrentFinancialInstruments2024-03-3106682721ns5:ShareCapital2025-03-3106682721ns5:ShareCapital2024-03-3106682721ns5:RetainedEarningsAccumulatedLosses2025-03-3106682721ns5:RetainedEarningsAccumulatedLosses2024-03-3106682721ns5:LandBuildings2024-04-012025-03-3106682721ns5:PlantMachinery2024-04-012025-03-3106682721ns5:LandBuildings2024-03-3106682721ns5:PlantMachinery2024-03-3106682721ns5:LandBuildings2025-03-3106682721ns5:PlantMachinery2025-03-3106682721ns5:LandBuildings2024-03-3106682721ns5:PlantMachinery2024-03-3106682721ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3106682721ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3106682721ns5:RetainedEarningsAccumulatedLosses2024-03-3106682721ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-31
REGISTERED NUMBER: 06682721 (England and Wales)















Financial Statements for the Year Ended 31 March 2025

for

FACEmed Limited

FACEmed Limited (Registered number: 06682721)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


FACEmed Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: Miss M M Berrange
Mr C G Berrange
N J Baldock





SECRETARY: Miss M M Berrange





REGISTERED OFFICE: 1 Sopwith Crescent
Shotgate
Wickford
Essex
SS11 8YU





REGISTERED NUMBER: 06682721 (England and Wales)





AUDITORS: Sygma Chartered Accountants
1 Sopwith Crescent
Wickford
Essex
SS11 8YU

FACEmed Limited (Registered number: 06682721)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,218,185 768,817

CURRENT ASSETS
Stocks 25,000 25,000
Debtors 5 74,234 43,649
Cash at bank and in hand 716,603 479,198
815,837 547,847
CREDITORS
Amounts falling due within one year 6 701,852 470,245
NET CURRENT ASSETS 113,985 77,602
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,332,170

846,419

PROVISIONS FOR LIABILITIES 194,913 29,000
NET ASSETS 1,137,257 817,419

CAPITAL AND RESERVES
Called up share capital 21 21
Retained earnings 7 1,137,236 817,398
1,137,257 817,419

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 December 2025 and were signed on its behalf by:





Miss M M Berrange - Director


FACEmed Limited (Registered number: 06682721)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

FACEmed Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - in accordance with the property
Plant and machinery etc - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

FACEmed Limited (Registered number: 06682721)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2024 - 8 ) .

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 April 2024 345,625 757,049 1,102,674
Additions - 547,716 547,716
At 31 March 2025 345,625 1,304,765 1,650,390
DEPRECIATION
At 1 April 2024 22,211 311,646 333,857
Charge for year 9,702 88,646 98,348
At 31 March 2025 31,913 400,292 432,205
NET BOOK VALUE
At 31 March 2025 313,712 904,473 1,218,185
At 31 March 2024 323,414 445,403 768,817

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 47,541 18,294
Other debtors 26,693 25,355
74,234 43,649

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade creditors 99,360 74,700
Taxation and social security 122,342 118,945
Other creditors 480,150 276,600
701,852 470,245

FACEmed Limited (Registered number: 06682721)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. RESERVES
Retained
earnings
£   

At 1 April 2024 817,398
Profit for the year 597,560
Dividends (277,722 )
At 31 March 2025 1,137,236

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

A Chandler FCA (Senior Statutory Auditor)
for and on behalf of Sygma Chartered Accountants

9. RELATED PARTY DISCLOSURES

The company is controlled by its director Ms M Berrange, who also controls Face Invest Limited, a minority ashareholder in the company.

During the year the company occupied commercial premises owned by Face Invest Ltd for which no rent was charged. This transaction was not conducted on an arm’s length basis.

Dividends totalling £132,000 (2024: £132,000) were paid during the year to Face Invest Ltd.